17th International Conference on Nephrology & Urology
Helsinki University Hospital, Finland
Riitta Lassila has completed her MD in 1983 from Helsinki University, PhD in 1989, and postdoctoral studies at Mount Sinai University School of Medicine in N.Y. She is an internist and the Head of Coagulation Disorders Unit in Helsinki University Hospital since 2000 and Professor of Coagulation Medicine in Helsinki University since 2013. She has published more than 220 papers in peer-reviewed journals and has served as editor in Thrombosis Research and editorial board member of Haemophilia. She is the secretary of European Association of Haemophilia and Allied Disorders and steering committee member of EUHANET and EUHASS. She is CSO in Aplagon Oy developing APACs as pharamceutical entities.
Abstract : Locally acting antiplatelet and anticoagulant APAC, a mimic of heparin proteoglycan, inhibits acute ischemic kidney injury